PTH Antagonist(Crinetics Pharmaceuticals)

N/A

Report date: 2025/08/15 14:29:33
NME

Base Information

Drug NamePTH Antagonist(Crinetics Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionParathyroid hormone receptor antagonists
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHyperparathyroidism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrinetics Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHyperparathyroidism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A